“As we close 2025, I’m incredibly proud of what the TrialX team has built over more than 17 years of innovation and delivery. From launching our first app in 2008 with pioneers like Google Health and…
2025 has seen 43 novel FDA drug approvals – new drugs never before approved or marketed in the U.S for a condition – introducing high-impact therapies that are redefining what “breakthrough” truly means. This year’s portfolio…
“As we close 2024, I’m proud of the transformative strides we’ve made in advancing software solutions for patient recruitment and remote data collection. From simplifying recruitment workflows with AI-powered tools and streamlining volunteer registries to enhancing…
Today we bid farewell to 2009 and its been a great year. It has been an exciting, challenging and rewarding to get TrialX live and up and continuously evolving. And we thank all our users who…
